Updating a meta analysis of intervention research with challenging behaviour


05-May-2019 18:55

doi:10.1056/NEJM199910073411501Pub Med Google Scholar Crossref Flegal KM, Kit BK, Orpana H, Graubard BI. doi:10.1001/jama.2012.113905Pub Med Google Scholar Crossref Yu E, Ley SH, Manson JE, et al. doi:10.7326/M16-1390Pub Med Google Scholar Crossref Flegal KM, Ioannidis JPA. doi:10.1016/j.jclinepi.20Pub Med Google Scholar Crossref Padwal RS, Pajewski NM, Allison DB, Sharma AM. Access to society journal content varies across our titles.If you have access to a journal via a society or association membership, please browse to your society journal, select an article to view, and follow the instructions in this box.Contact us if you experience any difficulty logging in.Chronic disease management: Aim of the intervention was the management of an existing chronic disease. Excluded study design: Study did not use an included design. Literature Search Strategies for Primary Literaturee Methods. Quality Assessment Criteria for Randomized Clinical Trialse Table 1. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. doi:10.1001/jama.295.6.676Pub Med Google Scholar Crossref Acharya NV, Wilton LV, Shakir SA. doi:10.1038/0803323Pub Med Google Scholar Crossref Ackermann RT, Finch EA, Brizendine E, Zhou H, Marrero DG. doi:10.1016/j.amepre.20Pub Med Google Scholar Crossref Ackermann RT, Liss DT, Finch EA, et al. doi:10.2105/AJPH.2015.302641Pub Med Google Scholar Crossref Allison DB, Gadde KM, Garvey WT, et al. doi:10.1038/oby.2011.330Pub Med Google Scholar Crossref Anderson AS, Craigie AM, Caswell S, et al. doi:10.1136/bmj.g1823Pub Med Google Scholar Crossref Apovian CM, Aronne L, Rubino D, et al; COR-II Study Group. doi:10.1002/oby.20309Pub Med Google Scholar Crossref Appel LJ, Clark JM, Yeh HC, et al. doi:10.1056/NEJMoa1108660Pub Med Google Scholar Crossref Aronne LJ, Wadden TA, Peterson C, Winslow D, Odeh S, Gadde KM. doi:10.1002/oby.20584Pub Med Google Scholar Crossref Astrup A, Carraro R, Finer N, et al; NN8022-1807 Investigators. doi:10.1038/ijo.2011.158Pub Med Google Scholar Crossref Aveyard P, Lewis A, Tearne S, et al. doi:10.1016/S0140-6736(16)31893-1Pub Med Google Scholar Crossref Bakris G, Calhoun D, Egan B, Hellmann C, Dolker M, Kingma I; Orlistat and Resistant Hypertension Investigators. doi:10.1097/00004872-200211000-00026Pub Med Google Scholar Crossref Befort CA, Klemp JR, Sullivan DK, et al. doi:10.1002/oby.21625Pub Med Google Scholar Crossref Bennett GG, Warner ET, Glasgow RE, et al; Be Fit, Be Well Study Investigators. doi:10.1001/archinternmed.2012.1Pub Med Google Scholar Crossref Bhopal RS, Douglas A, Wallia S, et al. doi:10.1016/S2213-8587(13)70204-3Pub Med Google Scholar Crossref Broom I, Hughes E, Dodson P, Reckless J. Google Scholar Broom I, Wilding J, Stott P, Myers N; UK Multimorbidity Study Group. Pub Med Google Scholar Burke V, Beilin LJ, Cutt HE, Mansour J, Wilson A, Mori TA. doi:10.1097/010000170388.61579.4f Pub Med Google Scholar Crossref Cadmus-Bertram L, Nelson SH, Hartman S, Patterson RE, Parker BA, Pierce JP. doi:10.1007/s10865-016-9735-9Pub Med Google Scholar Crossref Chirinos DA, Goldberg RB, Llabre MM, et al. doi:10.1007/s10865-016-9721-2Pub Med Google Scholar Crossref Christian JG, Byers TE, Christian KK, et al. doi:10.1016/20Pub Med Google Scholar Crossref Cussler EC, Teixeira PJ, Going SB, et al. doi:10.1038/oby.2008.19Pub Med Google Scholar Crossref Davidson MH, Hauptman J, Di Girolamo M, et al. doi:10.1001/jama.281.3.235Pub Med Google Scholar Crossrefde Vos BC, Runhaar J, Bierma-Zeinstra SM. doi:10.1007/s00394-013-0505-y Pub Med Google Scholar Crossref Demark-Wahnefried W, Jones LW, Snyder DC, et al. doi:10.1002/cncr.28761Pub Med Google Scholar Crossref Derosa G, Mugellini A, Ciccarelli L, Fogari R. doi:10.1016/S0149-2918(03)80070-XPub Med Google Scholar Crossref Eaton CB, Hartman SJ, Perzanowski E, et al. doi:10.1370/afm.1952Pub Med Google Scholar Crossref Farr OM, Upadhyay J, Gavrieli A, et al. doi:10.2337/db16-0635Pub Med Google Scholar Crossref Fidler MC, Sanchez M, Raether B, et al; BLOSSOM Clinical Trial Group. doi:10.1210/jc.2011-1256Pub Med Google Scholar Crossref Finer N, James WP, Kopelman PG, Lean ME, Williams G. doi:10.1038/0801128Pub Med Google Scholar Crossref Fitzgibbon ML, Stolley MR, Schiffer L, Sharp LK, Singh V, Dyer A. doi:10.1038/oby.2010.47Pub Med Google Scholar Crossref Gadde KM, Allison DB, Ryan DH, et al. Using social and mobile tools for weight loss in overweight and obese young adults (Project SMART): a 2 year, parallel-group, randomised, controlled trial. Waste the waist: a pilot randomised controlled trial of a primary care based intervention to support lifestyle change in people with high cardiovascular risk. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial [published corrections appear in Lancet. Characteristics of All Randomized Clinical Trials, by Intervention Type and Author (k=124)e Table 2. Comparison of two methods to detect publication bias in meta-analysis. Safety profile of orlistat: results of a prescription-event monitoring study. Translating the diabetes prevention program into the community: the DEPLOY pilot study. A randomized comparative effectiveness trial for preventing type 2 diabetes. Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). The impact of a bodyweight and physical activity intervention (Be WEL) initiated through a national colorectal cancer screening programme: randomised controlled trial. A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II). Comparative effectiveness of weight-loss interventions in clinical practice. Evaluation of phentermine and topiramate versus phentermine/topiramate extended-release in obese adults. Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. Screening and brief intervention for obesity in primary care: a parallel, two-arm, randomised trial. Orlistat improves blood pressure control in obese subjects with treated but inadequately controlled hypertension. Weight loss maintenance strategies among rural breast cancer survivors: the rural women connecting for better health trial. Obesity treatment for socioeconomically disadvantaged patients in primary care practice. Effect of a lifestyle intervention on weight change in South Asian individuals in the UK at high risk of type 2 diabetes: a family-cluster randomised controlled trial. The role of orlistat in the treatment of obese patients with mild to moderate hypercholesterolaemia: consequences for coronary risk. Randomised trial of the effect of orlistat on body weight and cardiovascular disease risk profile in obese patients: UK Multimorbidity Study. Effects of a lifestyle programme on ambulatory blood pressure and drug dosage in treated hypertensive patients: a randomized controlled trial. Randomized trial of a phone- and web-based weight loss program for women at elevated breast cancer risk: the HELP study. Lifestyle modification and weight reduction among low-income patients with the metabolic syndrome: the CHARMS randomized controlled trial. A computer support program that helps clinicians provide patients with metabolic syndrome tailored counseling to promote weight loss. Maintenance of weight loss in overweight middle-aged women through the Internet. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. Effectiveness of a tailor-made weight loss intervention in primary care. Daughters and Mothers Against Breast Cancer (DAMES): main outcomes of a randomized controlled trial of weight loss in overweight mothers with breast cancer and their overweight daughters. Randomized, double-blind, placebo-controlled comparison of the action of orlistat, fluvastatin, or both on anthropometric measurements, blood pressure, and lipid profile in obese patients with hypercholesterolemia prescribed a standardized diet. A randomized clinical trial of a tailored lifestyle intervention for obese, sedentary, primary care patients. Lorcaserin administration decreases activation of brain centers in response to food cues and these emotion- and salience-related changes correlate with weight loss effects: a 4-week-long randomized, placebo-controlled, double-blind clinical trial. A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial. One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor. Obesity Reduction Black Intervention Trial (ORBIT): 18-month results. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial [published correction appears in Lancet. Reasons for exclusion: Aim: Study aim was not relevant. Intentional weight loss and incidence of obesity-related cancers: the Iowa Women’s Health Study. Weight loss and coronary heart disease: sensitivity analysis for unmeasured confounding by undiagnosed disease. Attribution of causes of weight loss and weight gain to 3-year mortality in older adults: results from the Longitudinal Aging Study Amsterdam. Prospective study of intentionality of weight loss and mortality in older women: the Iowa Women’s Health Study. Prospective study of intentional weight loss and mortality in overweight white men aged 40-64 years. Intention to lose weight, weight changes, and 18-y mortality in overweight individuals without co-morbidities. Voluntary and involuntary weight loss: associations with long term mortality in 9,228 middle-aged and elderly men. Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. The impact of bariatric surgery on obstructive sleep apnea: a systematic review. Changes in quality of life and body image after gastric bypass surgery. Mental health conditions among patients seeking and undergoing bariatric surgery: a meta-analysis. Change in pain and physical function following bariatric surgery for severe obesity. Role of the gut on glucose homeostasis: lesson learned from metabolic surgery. Setting: Study was not conducted in a country relevant to United States practice or not conducted in, recruited from, or feasible for primary care or a health system. doi:10.1038/oby.2011.329Pub Med Google Scholar Crossref Rodriguez-Cristobal JJ, Alonso-Villaverde C, Panisello JM, et al. doi:10.1186/s12875-017-0644-y Pub Med Google Scholar Crossref Phelan S, Hagobian T, Brannen A, et al. doi:10.1001/jama.2017.7119Pub Med Google Scholar Crossref Trials of Hypertension Prevention Collaborative Research Group. doi:10.1001/jama.1992.03480090061028Pub Med Google Scholar Crossref Uusitupa M, Peltonen M, Lindström J, et al; Finnish Diabetes Prevention Study Group. doi:10.1371/0005656Pub Med Google Scholar Crossref Shea MK, Nicklas BJ, Houston DK, et al. doi:10.3945/ajcn.110.006379Pub Med Google Scholar Crossref Ratner R, Goldberg R, Haffner S, et al; Diabetes Prevention Program Research Group. doi:10.2337/diacare.28.4.888Pub Med Google Scholar Crossref Rubin RR, Peyrot M, Wang NY, et al. doi:10.1007/s11136-013-0363-3Pub Med Google Scholar Crossref Florez H, Pan Q, Ackermann RT, et al; Diabetes Prevention Program Research Group. doi:10.1007/s11606-012-2122-5Pub Med Google Scholar Crossref Ackermann RT, Edelstein SL, Narayan KM, et al; Diabetes Prevention Program Research Group. doi:10.1038/oby.2009.114Pub Med Google Scholar Crossref Demark-Wahnefried W, Colditz GA, Rock CL, et al; ENERGY Trial Group. doi:10.1007/s10549-015-3627-5Pub Med Google Scholar Crossref Mc Carroll ML, Armbruster S, Frasure HE, et al. doi:10.1016/j.ygyno.20Pub Med Google Scholar Crossref Sarwer DB, Moore RH, Diewald LK, et al; POWER-UP Research Group. doi:10.1038/ijo.2013.93Pub Med Google Scholar Crossref Swencionis C, Wylie-Rosett J, Lent MR, et al. doi:10.1037/a0029186Pub Med Google Scholar Crossref Lindström J, Peltonen M, Eriksson JG, et al; Finnish Diabetes Prevention Study (DPS). doi:10.1007/s00125-012-2752-5Pub Med Google Scholar Crossrefle Roux CW, Astrup A, Fujioka K, et al; SCALE Obesity Prediabetes NN8022-1839 Study Group. doi:10.1016/S0140-6736(17)30069-7Pub Med Google Scholar Crossref Williamson DF, Pamuk E, Thun M, Flanders D, Byers T, Heath C. doi:10.1093/a117386Pub Med Google Scholar Crossref Wannamethee SG, Shaper AG, Walker M. doi:10.1136/jech.2003.015651Pub Med Google Scholar Crossref Gregg EW, Gerzoff RB, Thompson TJ, Williamson DF.

updating a meta analysis of intervention research with challenging behaviour-90

late 20s dating

Background: This meta-analysis of interventions with challenging behaviour in children with disabilities updates a comprehensive meta-analysis that previously addressed reported standards of practice and effectiveness of different strategies.Population Characteristics for All Randomized Clinical Trials, Sorted by Intervention Type and Author (k=124)e Table 3. Preventive Services Task Force Evidence Syntheses, Formerly Systematic Evidence Reviews.